Metrodora Ventures — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Biophybiophy.aiPre-Seed · Nov 2023 · $5M

BioPhy builds a suite of modular AI tools for pharmaceutical companies, automating quality, compliance, manufacturing, and supply-chain tasks such as SOP–regulation gap analysis, document consolidation, and IQ/OQ/PQ validation.

AI & Machine LearningBiotechEnterprise SoftwarePhiladelphia, US

DAVID LATSHAW II(CHIEF EXECUTIVE OFFICER)

BoardPHILIP BROWNE(Director)DANIEL SCIUBBA(Director)

Co-investorsAudere Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.